Page last updated: 2024-08-24

pyrrolidine dithiocarbamate and Cardio-Renal Syndrome

pyrrolidine dithiocarbamate has been researched along with Cardio-Renal Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bongartz, LG; Braam, B; Cheng, C; Cramer, MJ; Doevendans, PA; Gaillard, CA; Goldschmeding, R; Joles, JA; Oosterhuis, NR; van Koppen, A; Verhaar, MC; Xu, YJ1

Other Studies

1 other study(ies) available for pyrrolidine dithiocarbamate and Cardio-Renal Syndrome

ArticleYear
Targeting multiple pathways reduces renal and cardiac fibrosis in rats with subtotal nephrectomy followed by coronary ligation.
    Acta physiologica (Oxford, England), 2017, Volume: 220, Issue:3

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Cardio-Renal Syndrome; Coronary Vessels; Cyclic N-Oxides; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fibrosis; Heart; Kidney; Kidney Function Tests; Ligation; Losartan; Male; Metoprolol; Molsidomine; Nephrectomy; NF-kappa B; Nitric Oxide Donors; Pyrrolidines; Rats, Inbred Lew; Spin Labels; Sympatholytics; Thiocarbamates

2017